Showing 1-20 of 22 articles
Coronary interventions
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial February 7, 2020 | 10.4244/EIJ-D-18-00944
Coronary interventions
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation September 20, 2019 | 10.4244/EIJ-D-18-00422
Coronary interventions
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial July 19, 2019 | 10.4244/EIJ-D-18-00499
Coronary interventions
Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years July 19, 2019 | 10.4244/EIJ-D-18-00381
Coronary interventions
On-line three-dimensional OFDI guided PCI vs. angiography guided in bifurcation lesions: design and rationale of the randomized OPTIMUM trial July 9, 2019 | 10.4244/EIJ-D-18-00902
Coronary interventions
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication. July 9, 2019 | 10.4244/EIJ-D-18-01190
Coronary interventions
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials May 20, 2019 | 10.4244/EIJ-D-18-00607
Coronary interventions
Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study May 7, 2019 | 10.4244/EIJ-D-18-01201
Coronary interventions
Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs February 7, 2019 | 10.4244/EIJ-D-18-00391
Coronary interventions
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial December 20, 2018 | 10.4244/EIJ-D-18-00461
Coronary interventions
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial) December 7, 2018 | 10.4244/EIJ-D-18-00839
Coronary interventions
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) October 12, 2018 | 10.4244/EIJ-D-18-00301
STEMI
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial August 24, 2018 | 10.4244/EIJ-D-17-00884
Coronary interventions
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial July 20, 2018 | 10.4244/EIJ-D-17-01152
Coronary interventions
Interventional cardiology: review of the year 2017 April 20, 2018 | 10.4244/EIJ-D-18-00066